We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AUTL market cap is 818.27M. The company's latest EPS is USD -1.1969 and P/E is -3.91.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.37M | 3.83M | 2.07M | 482k | -858k |
Operating Income | -47.24M | -35.26M | -38.55M | -47.38M | -49.09M |
Net Income | -42.77M | -26.95M | -39.81M | -45.55M | -45.85M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.91M | 1.72M | 2.33M | 6.36M | 1.7M |
Operating Income | -146.06M | -168.15M | -163.65M | -138.9M | -183.51M |
Net Income | -123.85M | -142.09M | -142.1M | -148.84M | -208.38M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 263.83M | 490.27M | 459.97M | 450.99M | 406.1M |
Total Liabilities | 102.68M | 191.6M | 193.05M | 221.66M | 225.58M |
Total Equity | 161.15M | 298.67M | 266.92M | 229.34M | 180.52M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 303.53M | 294.24M | 405.56M | 490.27M | 375.38M |
Total Liabilities | 48.69M | 84.21M | 92.24M | 191.6M | 263.91M |
Total Equity | 254.84M | 210.03M | 313.32M | 298.67M | 111.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | -112.31M | -42.42M | -80.57M | -120.75M |
Investing | N/A | -10.84M | -3.62M | -8.01M | -9.51M |
Financing | N/A | 223.61M | -691k | -910k | -906k |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -101.48M | -117.76M | -117.86M | -112.31M | -145.59M |
Investing | -18.67M | -14.68M | -8.86M | -10.84M | -10.99M |
Financing | 108.86M | 74.42M | 284.06M | 223.61M | -883k |
Market Cap | 818.27M |
Price to Earnings Ratio | -3.91 |
Price to Sales Ratio | 477.55 |
Price to Cash Ratio | 3.4 |
Price to Book Ratio | 7.31 |
Dividend Yield | - |
Shares Outstanding | 174.1M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (0.21%) |
Company Name | Autolus Therapeutics PLC |
Address |
191 wood lane london W12 7FP |
Website | https://www.autolus.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions